Navigation Links
Contained Medication System Now Keeping Hospitals Compliant With Latest Legislation
Date:8/9/2011

BETHLEHEM, Pa., Aug. 9, 2011 /PRNewswire/ -- In its efforts to further advance best practices with the continuous improvement of safety, B. Braun Medical Inc. (B. Braun) announced today that its OnGuard™ Contained Medication System can help increase institution and new legislation compliance regarding the protection of healthcare workers from exposure to hazardous drugs.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

Senate Bill 5594 has recently directed The Washington State Department of Labor & Industries to adopt requirements for the handling of hazardous drugs in protecting healthcare workers from occupational drug exposure. Rules focused on proper ventilation, protective equipment, and safe handling practices have been addressed in detail. Amid many reports nationally on the adverse health effects of occupational hazardous drug exposure, Washington is the first state in the nation to require such protection for its workers.

Studies have shown certain drugs, such as chemotherapy agents, can be associated with a variety of both short-term and long-term health effects.(1)  OnGuard  is a next-generation closed system drug-transfer device. The innovative drug admixture and delivery system meets The American Society of Health-System Pharmacists (ASHP), National Institute for Occupational Safety and Health (NIOSH) and USP <797> safety guidelines and provides a new level of hazard protection for pharmacists and nurses on the frontline of chemotherapy preparation and administration.

"When you're preparing chemo every day and there is the looming threat of exposure to hazardous vapors, protecting your personal safety is of the utmost importance," said Chris Mangen of the Lucy Curci Cancer Center in Rancho Mirage, Calif. "The OnGuard system is easy-to-use and safe, helping eliminate the risks associated with typical chemo preparation."

Prior to Bill 5594, ASHP, NIOSH and USP <797> had each recommended the use of protective devices for the preparation of hazardous medications. After its passing, NIOSH teamed up with OSHA and The Joint Commission, sending a letter to all U.S. hospitals reinforcing the need to address safe drug handling at their facilities.

"This message has been out there, and with the passing of Bill 5594 it's becoming even stronger," said Rob Albert, Vice President, Pharmaceutical Marketing, B. Braun Medical Inc. "An investment in OnGuard is an opportunity for facilities to invest in and protect their most valuable assets – the health and well being of employees and patients."

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, email us at inquiry.us@bbraun.com or visit B. Braun at www.bbraunusa.com.

(1) CDC. NIOSH Alert: Preventing Occupational Exposure to Antineoplastic and Other Hazardous Drugs in Health Care Settings. Page 1. September 2004.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
2. More Than 1.5 Million Americans Sickened, Injured or Killed by Medication Errors Each Year; Seniors Most at Risk
3. RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
4. Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone
5. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
6. Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkins Lymphoma
7. FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder
8. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
9. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
10. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
11. Aching Back? Cholesterol Medication Might Help
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Research and ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" report ... In-Mold Electronics, Smart Skin, Structural Health Monitoring, ... Structural electronics involves electronic and/or electrical components ... replacing dumb structures such as vehicle bodies or ...
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):